Potential drug interactions with statins: Estonian register-based study

In Estonia, HMG-CoA reductase inhibitors are widely used to modify lipid levels but there are no current data on additional medicines prescribed alongside the statins. The aim of this study was to identify the frequency of potential clinically relevant interactions at a national level among an outpa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavronski, Maia, Volmer, Daisy, Hartikainen, Sirpa, Zharkovsky, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter Open 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152992/
https://www.ncbi.nlm.nih.gov/pubmed/28352703
http://dx.doi.org/10.1515/med-2015-0038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152992/
https://www.ncbi.nlm.nih.gov/pubmed/28352703
http://dx.doi.org/10.1515/med-2015-0038

Ejemplares similares